- Published at
- by gurufocus.com
positive
positive
CLINUVEL recruits 200 patients in Phase III vitiligo trial CUV105
First results of SCENESSE® study expected in 2H 2026
Executive summary Recruitment target of 200 vitiligo patients (Fitzpatrick skin type III-VI) in CUV105